In oxaliplatin-resistant CRC cells, reduced KLF4 expression weakens its transcriptional repression of PiHL, resulting in PiHL upregulation and activation of the EZH2/HMGA2/PI3K/Akt signaling pathway to promote oxaliplatin resistance (63). This evidence concerns the gene KLF4 and colorectal carcinoma.